Real-time enrollment status for this candida infection clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 11:52 AM UTC
| NCT Number | NCT05421858 |
| Recruiting Status | Recruiting |
| Condition | Candida infection |
| Phase | PHASE3 |
| Target Enrollment | 450 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Basilea Pharmaceutica |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 18, 2026: Clinical trial NCT05421858 is currently recruiting participants. This phase3 study for candida infection is actively seeking new participants at 23 locations across the United States. The study is sponsored by Basilea Pharmaceutica. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05421858 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05421858 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.